Last update 08 Jul 2025

99mTc-Sulesomab

Overview

Basic Info

Drug Type
Radiolabeled antibody, Diagnostic radiopharmaceuticals
Synonyms
99mTc-Sulesomab, Immunoglobulin G1 (mouse monoclonal IMMU-MN3 Fab' fragment gamma-chain anti-human NCA-90 granulocyte cell antigen), disulfide with mouse monoclonal IMMU-MN3 light chain, ImmuRAID MN3 Tc 99m
+ [3]
Target
Action
inhibitors
Mechanism
CEACAM6 inhibitors(Carcinoembryonic antigen related cell adhesion molecule 6 inhibitors)
Active Indication
Inactive Indication
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
European Union (14 Feb 1997),
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
Boost your research with our ADC technology data.

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetic foot ulcer
European Union
14 Feb 1997
Diabetic foot ulcer
Iceland
14 Feb 1997
Diabetic foot ulcer
Liechtenstein
14 Feb 1997
Diabetic foot ulcer
Norway
14 Feb 1997
Osteomyelitis
European Union
14 Feb 1997
Osteomyelitis
Iceland
14 Feb 1997
Osteomyelitis
Liechtenstein
14 Feb 1997
Osteomyelitis
Norway
14 Feb 1997
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
53
99m Tc-sulesomab
xmiirnxhbl(ayeykmzvwf) = nllardyyyo bdiacdegil (ylxezrlika )
Positive
11 Sep 2017
99m Tc-nanocolloid
xicepsrizl(mjnibtdrrk) = qohoquhevc gnxbhepmew (rxokneiksc )
Not Applicable
55
kdwbbuuuop(yehdearrpv) = cyrrjkddrj ntpxjgwupk (fzgkanlfoq )
Positive
21 Sep 2016
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free